XML 32 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Statement of Cash Flows [Abstract]    
Interest Paid $ 4,736,000 $ 0
Nonrecurring basis (assets) 96,528,000 156,000
Operating activities:    
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 48,741,000 (1,824,000)
Adjustments to reconcile net income to net cash used in operating activities:    
Net unrealized gain on mortgage loans (65,130,000) (1,128,000)
Net realized gain on mortgage loans (9,321,000) (387,000)
Gains (Losses) on Sales of Other Real Estate (55,000) 0
Depreciation, Depletion, Amortization and Other Noncash Expense 403,000 0
Real estate depreciation and amortization 48,000 0
Amortization of deferred financing costs 608,000 30,000
Share-based compensation 3,316,000 214,000
Changes in operating assets and liabilities:    
Increase (Decrease) in Accounts and Other Receivables 502,000 0
Related party receivables (53,000) 518,000
Prepaid expenses and other assets (530,000) (360,000)
Accounts payable and accrued liabilities 1,118,000 711,000
Related party payables 871,000 (200,000)
Net cash used in operating activities (19,530,000) (2,426,000)
Investing activities:    
Investment in mortgage loans (611,357,000) (88,257,000)
Investment in real estate 0 (278,000)
Investment in renovations (447,000) 0
Real Estate Tax Advances (6,259,000) 0
Proceeds from Sale of Loans Held-for-investment 32,775,000 88,000
Payments for (Proceeds from) Loans and Leases 3,129,000 0
Proceeds from Sale of Wholly Owned Real Estate and Real Estate Acquired in Settlement of Loans 734,000 0
Change in restricted cash (1,456,000) 0
Net cash used in investing activities (582,881,000) (88,447,000)
Financing activities:    
Proceeds from issuance of preferred stock 250,000,000 0
Cost of issuance of preferred stock (1,114,000) 0
Issuance of common stock, including stock option exercises 2,732,000 0
Repurchase of common stock (44,565,000) 0
Payment of tax withholdings on exercise of stock options (2,714,000) 0
Cost of issuance of common stock 0 (73,000)
Capital contribution from noncontrolling interest 468,491,000 0
Payments of Ordinary Dividends, Noncontrolling Interest (27,398,000) 0
Proceeds from repurchase agreement 127,664,000 12,926,000
Repayments of repurchase agreement (30,096,000) 0
Payment of deferred financing costs (123,000) (1,100,000)
Net cash provided by financing activities 742,877,000 11,753,000
Net increase/(decrease) in cash and cash equivalents 140,466,000 (79,120,000)
Cash and cash equivalents as of beginning of the period 140,000,000 105,014,000
Cash and cash equivalents as of end of the period 280,466,000 25,894,000
Supplemental disclosure of cash flow information    
Changes in accrued for equity issuance costs 183,000 370,000
Changes in receivables from mortgage loan dispositions, payments and real estate tax advances to borrowers, net $ 1,247,000 $ 1,858,000